Ozempic breasts refer to changes in breast size or shape due to weight loss from GLP-1 drugs. Here’s how and why this side ...

It’s difficult to fathom that the health of half the world’s population is underserved. But it’s a hard truth. There are many conditions that disproportionately impact women. Other conditions and ...

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...

Knee cartilage is not designed for high stress loads. People who are overweight or obese are at a higher risk of developing osteoarthritis because of the extra stress on their knee joints, with many ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication ...

Ministers have been urged to ditch "gimmicks and soundbites" while addressing the soaring cost of obesity to the NHS.

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

Lexaria hopes to discover whether the DehydraTECH processing of semaglutide improves its biodistribution in any significant way compared to conventional orally administered semaglutide formulation ...

Why is bulldozer justice relevant to the UPSC Exam? What significance do topics like the weight-loss drug Semaglutide, the ...

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...